This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.
Print Document
View Excel Document
Cover
Document and Entity Information
Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) (Parenthetical)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
Notes to Financial Statements
Organization
Summary of Significant Accounting Policies
Fair Value Measurements
Available-for-sale Securities
Balance Sheet Components
Intangible Assets and Goodwill
Commitments and Contingencies
Sanofi Collaboration Agreement
Redeemable Convertible Preferred Stock
Common Stock
Stock-Based Compensation
Net Loss Per Share Attributable to Common Stockholders
Related Party Relationships
Accounting Policies
Summary of Significant Accounting Policies (Policies)
Notes Tables
Fair Value Measurements (Tables)
Available-for-sale Securities (Tables)
Balance Sheet Components (Tables)
Intangible Assets and Goodwill (Tables)
Commitments and Contingencies (Tables)
Common Stock (Tables)
Stock-Based Compensation (Tables)
Net Loss Per Share Attributable to Common Stockholders (Tables)
Notes Details
Organization - Additional Information (Details)
Summary of Significant Accounting Policies - Additional Information (Details)
Fair Value Measurements - Schedule of Financial Assets Measured at Fair Value (Details)
Fair Value Measurements - Additional Information (Details)
Available-for-sale Securities - Summary of Estimated Value of Available-for-sale Securities and Cash Equivalents and Gross Unrealized Gains and Losses (Details)
Available-for-sale Securities - Summary of Amortized Cost and Estimated Fair Value of Available-for-sale Securities by Contractual Maturity (Details)
Balance Sheet Components - Schedule of Property and Equipment, Net (Details)
Balance Sheet Components - Additional Information (Details)
Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details)
Intangible Assets and Goodwill - Schedule of Intangibles Assets, Net (Details)
Intangible Assets and Goodwill - Additional Information (Details)
Intangible Assets and Goodwill - Schedule of Future Amortization Expense (Details)
Intangible Assets and Goodwill - Summary of Change in Carrying Value of Goodwill (Details)
Commitment and Contingencies - Additional Information (Details)
Commitment and Contingencies - Summary of Balance Sheet Classification of Lease Liabilities (Details)
Commitment and Contingencies - Schedule of Maturities of Operating Lease Liabilities (Details)
Sanofi Collaboration Agreement - Additional Information (Details)
Redeemable Convertible Preferred Stock - Additional Information (Details)
Common Stock - Additional Information (Details)
Common Stock - Schedule of Common Stock Reserved on Converted Basis for Future Issuance (Details)
Stock-Based Compensation - Additional Information (Details)
Stock-Based Compensation - Summary of Option Activity Under the Plan (Details)
Stock-Based Compensation - Summary of RSUs Activity Under the Plan (Details)
Stock-Based Compensation - Summary of Total Stock-Based Compensation Expense Related to Stock Options, RSUs and Employee Stock Purchase Plan (Details)
Net Loss Per Share Attributable to Common Stockholders - Computation of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details)
Net Loss Per Share Attributable to Common Stockholders - Schedule of Outstanding Potentially Dilutive Shares Excluded from Calculation of Diluted Net Loss Per Share (Details)
All Reports